SCHEMBL4700430

SCHEMBL4700430

CC=CCC(=O)CCCCCCC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.54
KMT2A Q03164 3/20 0.54
FAAH O00519 6/20 0.53
CES2 O00748 3/20 0.50
CES1 P23141 3/20 0.50
TERT O14746 3/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C19 P33261 2/20 0.48
BLM P54132 2/20 0.48
HSD17B10 Q99714 2/20 0.48
FABP4 P15090 2/20 0.48
PTPN1 P18031 2/20 0.48
PPARG P37231 2/20 0.48
PPARD Q03181 2/20 0.48
PPARA Q07869 2/20 0.48
GMNN O75496 1/20 0.48
USP2 O75604 1/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
CYP2C9 P11712 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8459328 1.00 MAPT (0.54) MAPTKMT2AFAAHCES2CES1
SCHEMBL8459329 1.00 MAPT (0.54) MAPTKMT2AFAAHCES2CES1
SCHEMBL8459576 0.98 FAAH (0.50) MAPTKMT2AFAAHCES2CES1
SCHEMBL8459575 0.98 FAAH (0.50) MAPTKMT2AFAAHCES2CES1
SCHEMBL6932381 0.91 CES1 (0.46) MAPTKMT2AFAAHCES2CES1
SCHEMBL8461565 0.91 CES1 (0.46) MAPTKMT2AFAAHCES2CES1
SCHEMBL11342101 0.85 MAPT (0.52) MAPTKMT2AFAAHCES2CES1
SCHEMBL11342110 0.85 MAPT (0.52) MAPTKMT2AFAAHCES2CES1
SCHEMBL9115731 0.84 KMT2A (0.56) MAPTKMT2AFAAHCES2CES1
SCHEMBL9112519 0.84 KMT2A (0.56) MAPTKMT2AFAAHCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020128644-A1 A PROCESS FOR BIO-TRANSFORMATION AND PRODUCTION OF D-LACTONES THEREOF TOJO VIKAS BIOTECH PVT. LTD. (IN) 2020-06-25 WO claimed
EP-0899342-B1 Process for the biotechnological production of Delta-decalactone and Delta-dodecalactone FIRMENICH & CIE (CH) 2004-05-06 EP claimed
US-6025170-A HYDROGENATION OF 2-DECEN-5-OLIDE OR 2-DODECEN-5-OLIDE, OR A DERIVATIVE THEREOF, BY A CLOSTRIDIUM GENUS BACTERIA FIRMENICH SA (CH) 2000-02-15 US claimed
EP-0899342-A2 Process for the biotechnological production of Delta-decalactone and Delta-dodecalactone FIRMENICH SA (CH) 1999-03-03 EP claimed
EP-0425001-B1 Natural delta-lactones and process of the production thereof TASTEMAKER BV (NL) 1996-01-17 EP claimed
US-11040941-B2 Alkanethioic acid derivative and perfume composition containing the same T. HASEGAWA CO., LTD. (JP) 2021-06-22 US disclosed
US-20200290958-A1 NOVEL ALKANETHIOIC ACID DERIVATIVE AND PERFUME COMPOSITION CONTAINING THE SAME T. HASEGAWA CO., LTD. (JP) 2020-09-17 US disclosed
WO-2020128644-A1 A PROCESS FOR BIO-TRANSFORMATION AND PRODUCTION OF D-LACTONES THEREOF TOJO VIKAS BIOTECH PVT. LTD. (IN) 2020-06-25 WO disclosed
US-9775371-B2 Decanoic acid derivatives and flavoring compositions T. HASEGAWA CO., LTD. (JP) 2017-10-03 US disclosed
EP-2989901-A1 AGENT FOR IMPARTING HARDENED OIL FLAVOR T. Hasegawa Co., Ltd. (JP) 2016-03-02 EP disclosed
US-20150359241-A1 AGENT FOR IMPARTING HYDROGENATED OIL FLAVOR T. HASEGAWA CO., LTD. (JP) 2015-12-17 US disclosed
US-20140377434-A1 NOVEL DECANOIC ACID DERIVATIVES AND FLAVORING COMPOSITIONS T. HASEGAWA CO., LTD. (JP) 2014-12-25 US disclosed
US-6025170-A HYDROGENATION OF 2-DECEN-5-OLIDE OR 2-DODECEN-5-OLIDE, OR A DERIVATIVE THEREOF, BY A CLOSTRIDIUM GENUS BACTERIA FIRMENICH SA (CH) 2000-02-15 US disclosed
US-6025170-A HYDROGENATION OF 2-DECEN-5-OLIDE OR 2-DODECEN-5-OLIDE, OR A DERIVATIVE THEREOF, BY A CLOSTRIDIUM GENUS BACTERIA FIRMENICH SA (CH) 2000-02-15 US disclosed
EP-0899342-A3 Process for the biotechnological production of Delta-decalactone and Delta-dodecalactone FIRMENICH SA (CH) 1999-12-08 EP disclosed
EP-0899342-A2 Process for the biotechnological production of Delta-decalactone and Delta-dodecalactone FIRMENICH SA (CH) 1999-03-03 EP disclosed
EP-0899342-A2 Process for the biotechnological production of Delta-decalactone and Delta-dodecalactone FIRMENICH SA (CH) 1999-03-03 EP disclosed
EP-0425001-B1 Natural delta-lactones and process of the production thereof TASTEMAKER BV (NL) 1996-01-17 EP disclosed
US-5128261-A NATURAL DELTA-LACTONES AND PROCESS OF THE PRODUCTION THEREOF PFW (NEDERLAND) B.V. (NL) 1992-07-07 US disclosed
EP-0425001-A1 Natural delta-lactones and process of the production thereof Tastemaker B.V. (NL) 1991-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200290958-A1 NOVEL ALKANETHIOIC ACID DERIVATIVE AND PERFUME COMPOSITION CONTAINING THE SAME TAS1R1, TRPA1, NAT1 MAPT 1763/4885KMT2A 719/4885FAAH 49/4885
US-20140377434-A1 NOVEL DECANOIC ACID DERIVATIVES AND FLAVORING COMPOSITIONS TAS2R5, FFAR3, FFAR1 MAPT 3504/4885KMT2A 1199/4885FAAH 283/4885
US-11040941-B2 Alkanethioic acid derivative and perfume composition containing the same TAS1R1, TMT1A, TRPA1 MAPT 1514/4885KMT2A 727/4885FAAH 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.